Arovella Therapeutics Ltd (ALA.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -413 | -129 | 95 | -35 | -166 |
| Purchase Of Investment | N/A | -50 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -531 | -348 |
| Other Investing Activity | -19 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-432 | $-179 | $95 | $-566 | $-515 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,810 | 14,609 | 5,478 | 6,256 | 9,856 |
| Common Stock Repurchased | -1,288 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -72 | -68 | -58 |
| Financing Cash Flow | $15,522 | $14,609 | $5,407 | $6,188 | $9,799 |
| Exchange Rate Effect | 2 | 23 | N/A | N/A | N/A |
| Beginning Cash Position | 12,714 | 5,175 | 6,071 | 6,717 | 977 |
| End Cash Position | 20,877 | 12,714 | 5,175 | 6,071 | 6,717 |
| Net Cash Flow | $8,160 | $7,516 | $-896 | $-646 | $5,740 |
| Free Cash Flow | |||||
| Capital Expenditure | -413 | -129 | -3 | -566 | -515 |
| Free Cash Flow | -413 | -129 | -3 | -566 | -515 |